Nicolas Poirier

Chief Executive Officer presso OSE IMMUNOTHERAPEUTICS

Patrimonio netto: 1 M $ in data 31/03/2024

42 anni

Consumer Services

Health Technology

Profilo

Nicolas Poirier is currently the Chief Executive Officer & Director at OSE Immunotherapeutics SA since 2022.
Previously, he worked as a Project Manager at Effimune SA. Dr. Poirier has a graduate degree from the University of Nantes and Louis Pasteur University, and an undergraduate degree from the Centre d'Etudes Supérieures de Techniques Industrielles.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
OSE IMMUNOTHERAPEUTICS SA 0.89%	31/12/2022	192 802 ( 0.89% )	1 M $	31/03/2024

Posizioni attive di Nicolas Poirier

Società	Posizione	Inizio
OSE IMMUNOTHERAPEUTICS	Chief Executive Officer	07/10/2022

Tutte le posizioni attive di Nicolas Poirier

Precedenti posizioni note di Nicolas Poirier

Società	Posizione	Fine
Effimune SA Effimune SA BiotechnologyHealth Technology Effimune SA engages in the research and development of drugs for transplantation and immune-mediated diseases. It covers the identification of novel therapeutic targets, the development of therapeutics, pilot manufacturing, set-up of animal models, pre-clinical and early clinical development. The company was founded by Maryvonne Hiance, Bernard Vanhove and Sophie Brouard in 2007 and is headquartered in Nantes, France.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Nicolas Poirier

Formazione di Nicolas Poirier

University of Nantes	Graduate Degree
Centre d'Etudes Supérieures de Techniques Industrielles	Undergraduate Degree
Louis Pasteur University	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Nicolas Poirier

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
OSE IMMUNOTHERAPEUTICS	Health Technology

Aziende private	1
Effimune SA Effimune SA BiotechnologyHealth Technology Effimune SA engages in the research and development of drugs for transplantation and immune-mediated diseases. It covers the identification of novel therapeutic targets, the development of therapeutics, pilot manufacturing, set-up of animal models, pre-clinical and early clinical development. The company was founded by Maryvonne Hiance, Bernard Vanhove and Sophie Brouard in 2007 and is headquartered in Nantes, France.	Health Technology